Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bullock

Showing results (271-280 of 293) with videos related to

Pageof 30
Sort By:
Investigational New Drugs|July 13, 2019
Phase 1b study of a small molecule antagonist of human chemokine (C-C motif) receptor 2 (PF-04136309) in combination with nab-paclitaxel/gemcitabine in first-line treatment of metastatic pancreatic ductal adenocarcinomaMarcus Noel, Eileen M O'Reilly, Brian M Wolpin, et al.
Liver Cancer|May 14, 2026
A Phase 1b Study of Botensilimab and Balstilimab in Treatment-Refractory Hepatocellular CarcinomaAnthony B El-Khoueiry, Christopher H Lieu, Ghassan K Abou-Alfa, et al.
Medrxiv : the Preprint Server for Health Sciences|March 30, 2023
A Large-Scale Proteomics Resource of Circulating Extracellular Vesicles for Biomarker Discovery in Pancreatic CancerBruno Bockorny, Lakshmi Muthuswamy, Ling Huang, et al.
Elife|December 18, 2024
A large-scale proteomics resource of circulating extracellular vesicles for biomarker discovery in pancreatic cancerBruno Bockorny, Lakshmi Muthuswamy, Ling Huang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2017
HALO 202: Randomized Phase II Study of PEGPH20 Plus Nab-Paclitaxel/Gemcitabine Versus Nab-Paclitaxel/Gemcitabine in Patients With Untreated, Metastatic Pancreatic Ductal AdenocarcinomaSunil R Hingorani, Lei Zheng, Andrea J Bullock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2025
Botensilimab (Fc-enhanced anti-cytotoxic lymphocyte-association protein-4 antibody) Plus Balstilimab (anti-PD-1 antibody) in Patients With Relapsed/Refractory Metastatic SarcomasBreelyn A Wilky, Gary K Schwartz, Michael S Gordon, et al.
Journal for Immunotherapy of Cancer|December 23, 2025
Botensilimab (Fc-enhanced anti-CTLA-4 antibody) plus balstilimab (anti-PD-1 antibody) in patients with treatment-refractory ovarian cancerRebecca Porter, Bruno Bockorny, Bradley R Corr, et al.
The American Journal of Surgical Pathology|September 7, 2017
HPV-related Multiphenotypic Sinonasal Carcinoma: An Expanded Series of 49 Cases of the Tumor Formerly Known as HPV-related Carcinoma With Adenoid Cystic Carcinoma-like FeaturesJustin A Bishop, Simon Andreasen, Jen-Fan Hang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2018
A Phase II and Biomarker Study of Sorafenib Combined with Modified FOLFOX in Patients with Advanced Hepatocellular CarcinomaLipika Goyal, Hui Zheng, Thomas A Abrams, et al.
The American Journal of Surgical Pathology|June 19, 2018
Ectomesenchymal Chondromyxoid Tumor: A Neoplasm Characterized by Recurrent RREB1-MKL2 FusionsBrendan C Dickson, Cristina R Antonescu, Prokopios P Argyris, et al.
Pageof 30

Showing results (271-280 of 293) with videos related to

Sort By:
Pageof 30
Investigational New Drugs|July 13, 2019
Phase 1b study of a small molecule antagonist of human chemokine (C-C motif) receptor 2 (PF-04136309) in combination with nab-paclitaxel/gemcitabine in first-line treatment of metastatic pancreatic ductal adenocarcinomaMarcus Noel, Eileen M O'Reilly, Brian M Wolpin, et al.
Liver Cancer|May 14, 2026
A Phase 1b Study of Botensilimab and Balstilimab in Treatment-Refractory Hepatocellular CarcinomaAnthony B El-Khoueiry, Christopher H Lieu, Ghassan K Abou-Alfa, et al.
Medrxiv : the Preprint Server for Health Sciences|March 30, 2023
A Large-Scale Proteomics Resource of Circulating Extracellular Vesicles for Biomarker Discovery in Pancreatic CancerBruno Bockorny, Lakshmi Muthuswamy, Ling Huang, et al.
Elife|December 18, 2024
A large-scale proteomics resource of circulating extracellular vesicles for biomarker discovery in pancreatic cancerBruno Bockorny, Lakshmi Muthuswamy, Ling Huang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2017
HALO 202: Randomized Phase II Study of PEGPH20 Plus Nab-Paclitaxel/Gemcitabine Versus Nab-Paclitaxel/Gemcitabine in Patients With Untreated, Metastatic Pancreatic Ductal AdenocarcinomaSunil R Hingorani, Lei Zheng, Andrea J Bullock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2025
Botensilimab (Fc-enhanced anti-cytotoxic lymphocyte-association protein-4 antibody) Plus Balstilimab (anti-PD-1 antibody) in Patients With Relapsed/Refractory Metastatic SarcomasBreelyn A Wilky, Gary K Schwartz, Michael S Gordon, et al.
Journal for Immunotherapy of Cancer|December 23, 2025
Botensilimab (Fc-enhanced anti-CTLA-4 antibody) plus balstilimab (anti-PD-1 antibody) in patients with treatment-refractory ovarian cancerRebecca Porter, Bruno Bockorny, Bradley R Corr, et al.
The American Journal of Surgical Pathology|September 7, 2017
HPV-related Multiphenotypic Sinonasal Carcinoma: An Expanded Series of 49 Cases of the Tumor Formerly Known as HPV-related Carcinoma With Adenoid Cystic Carcinoma-like FeaturesJustin A Bishop, Simon Andreasen, Jen-Fan Hang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2018
A Phase II and Biomarker Study of Sorafenib Combined with Modified FOLFOX in Patients with Advanced Hepatocellular CarcinomaLipika Goyal, Hui Zheng, Thomas A Abrams, et al.
The American Journal of Surgical Pathology|June 19, 2018
Ectomesenchymal Chondromyxoid Tumor: A Neoplasm Characterized by Recurrent RREB1-MKL2 FusionsBrendan C Dickson, Cristina R Antonescu, Prokopios P Argyris, et al.
Pageof 30